Pharmaceutical

CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Li...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Follicular Lymphoma:...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Anaplastic Large Cel...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for B-Cell Non-Hodgkin L...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Relapsed Chronic Lym...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Refractory Chronic L...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Marginal Zone B-cell...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

KKM-191-D by Genuone Science for Type 2 Diabetes: Likel...

KKM-191-D is under clinical development by Genuone Science and is currently in t...

JY-302 by Jin Yang Pharmaceutical for Type 2 Diabetes: ...

JY-302 is under clinical development by Jin Yang Pharmaceutical and is currently...

STAT+: Wegovy’s successful heart trial raises a vital q...

What exactly is the relationship between weight and health? A landmark study of ...

Failed clinical trials don’t always spell doom for a ne...

A failed trial isn’t always an automatic deal killer for a new drug, as clinical...

STAT+: ‘No data more personal’: Patients, digital healt...

“We have so many people and things gathering data on us at all times, without an...

STAT+: Wegovy cardiovascular study has doctors seeing n...

The momentum around weight loss drugs is about to get even bigger in the wake of...

Ransomware attack shuts down hospital emergency rooms i...

In the latest edition of STAT's Health Tech newsletter: a ransomware attack wrea...

STAT+: More drugmakers are filing continuation patents ...

More drugmakers are filing continuation patents that allow them to sideline gene...

Half of people worldwide at risk of developing mental h...

Mental health conditions are common — but that "doesn't weaken or abrogate the f...